Anesthesiology Doctors in Beloit, WI Accepting Medicare

6 Anesthesiology doctors found. Showing 1 - 6

Hajera Fatima Taher, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1969 W. Hart Rd, Beloit, WI 53511 Phone: 608-364-5355

Steven Stephen Choung, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1969 W Hart Rd, Beloit Memorial Hospital, Beloit, WI 53511 Phone: 608-362-7444    Fax: 608-362-0417

Mohammed J Mohiuddin, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1969 W Hart Rd, Beloit Memorial Hospital, Beloit, WI 53511 Phone: 608-362-7444    Fax: 608-362-0417

Yusi Hezhao Kase, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1969 W Hart Rd, Beloit, WI 53511 Phone: 323-317-0487

Yon D Ough, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1969 W Hart Rd, Beloit, WI 53511 Phone: 608-362-7444

Hailong Wang, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1969 W Hart Rd, Beloit, WI 53511 Phone: 608-362-7444    Fax: 608-362-0417

News Archive

Will 'Cadillac tax' push employers to trim health insurance costs

Kaiser Health News staff writer Julie Appleby examines the potential reach of the Cadillac tax.

OA urges patients to stop smoking before surgery to protect their own health

During National Non-Smoking Week, Ontario's Anesthesiologists (OA) are once again urging patients to stop smoking before surgery in order to protect their own health. In addition, Ontario's Anesthesiologists estimate that if every smoker scheduled for surgery stopped 6-8 weeks prior to their procedure, approximately $122 million could be saved by the health care system.

New combination appears to be effective against cancer stem cells in pancreatic cancer

The new cancer medication sorafenib looks promising. Sorafenib is used for advanced liver and kidney cancer and also appears to be effective against cancer stem cells in pancreatic cancer. The team led by Professor Dr. Ingrid Herr, Head of the Department of Molecular Oncosurgery, a group of the Department of Surgery at Heidelberg University Hospital, (Managing Director: Professor Dr. Markus W. B-chler) in cooperation with the German Cancer Research Center, tested the new substance in mice and pancreatic cancer cells.

Trius receives patent protection for torezolid phosphate in the U.S.

Trius Therapeutics, Inc. announced today the issuance of Patent Number 7,816,379, entitled "Oxazolidinone Derivatives," by the United States Patent and Trademark Office (USPTO). The new patent, which is exclusively licensed to Trius, protects the Company's lead investigational drug, torezolid phosphate (TR-701), currently in Phase 3 clinical testing in patients with acute bacterial skin and skin structure infections (ABSSSI).

Read more Medical News

› Verified 5 days ago